Trump

Showing 15 posts of 111 posts found.

top_10_image

Top Ten most popular articles on Pharmafile.com this week

July 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Pfizer, Sanofi, Trump, top 10

In the week leading up to Donald Trump’s visit to the United Kingdom, the news has been dominated by the …

shutterstock_254160583

Trump forces Pfizer to back down and delay price hikes until 2019

July 11, 2018
Research and Development, Sales and Marketing Alex Azar, Donald Trump, Ian Read, Pfizer, President trump, Trump, druig pricing, pharma

Trump bared his teeth, and it paid off. Following his call-out of Pfizer after the US pharma giant ignored the …

donald_trump_september_3_2015

Trump slams Pfizer over price hikes, Pfizer responds

July 10, 2018
Manufacturing and Production, Sales and Marketing Donald Trump, Drug pricing, Pfizer, Trump, pharma

Price hiking in the pharmaceutical industry continues to persist, and has become ever more prominent in the public sphere thanks …

shutterstock_138095450

Unfazed by Trump, Pfizer hikes prices for 100 of its drugs

July 3, 2018
Manufacturing and Production, Sales and Marketing Pfizer, President trump, Trump, pharma, price hikes

After a campaign full of not-so-veiled threats directed at the pharma industry, and a presidency which has so far failed …

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 18, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, Novartis, Takeda, Trump, brexit, pharma, pharmafile, top ten

The year is flying by – it’s another Friday, and that means another Top Ten run-down.Perhaps the biggest story this …

novartis_side_building

Novartis’ top lawyer retires from role over botched Trump deal

May 16, 2018
Medical Communications, Research and Development Michael Cohen, Novartis, Trump, pharma

The saga of Novartis’ ill-advised $1.2 million deal with US President Donald Trump’s lawyer Michael Cohen continues to unfold as …

Novartis’ $1.2m payment to Trump’s lawyer raises more questions than answers

May 10, 2018
Medical Communications Essential Consultants, Michael Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis payment to President Trump’s personal lawyer, Michael Cohen, had seemed fairly odd from the beginning – with many asking …

michael_cohen

Novartis caught in the Stormy Daniels affair, after huge payment to Trump’s lawyer

May 9, 2018
Medical Communications, Research and Development Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis has suddenly found itself embroiled in the Stormy Daniels affair, after the lawyer representing her, Michael Avenatti, included the …

top_ten

Top Ten most popular articles on Pharmafile.com this week

February 16, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's disease, Roche, Top 10 news, Top ten news, Trump, biotech, drugs, pharma, pharmaceutical

Another week is finished and it’s been a disastrous one for research into a potential treatment for Alzheimer’s disease. Two of …

Trump’s drug pricing reforms lack bite

February 12, 2018
Sales and Marketing Drug pricing, President trump, Trump, biotech, drugs, pharma, pharmaceutical

President Trump’s rhetoric leading up to his election had the pharmaceutical industry very worried – his often quoted line about …

alex_azar_wwsg_photo_cropped

Trump nominee and ex-Lilly exec confirmed as US Health Secretary by Senate

January 25, 2018
Manufacturing and Production, Medical Communications, Sales and Marketing Alex Azar, Eli Lilly, President trump, Trump, US, pharma

Alex Azar, President’s Trump’s controversial pick for Health and Human Services Secretary (HHS), has been confirmed in the role after …

shutterstock_138095450

Proposed cuts to National Institutes of Health could delay up to 90% of US drug approvals

November 27, 2017
Research and Development, Sales and Marketing Donald Trump, FDA, NIH, National Institutes of Health, Trump, pharma

President Donald Trump’s budget proposes to cut funding to the National Institutes of Health by $7.2 billion or 21%. Researchers …

aedes_aegypti_mosquito

Budget cuts to the President’s Malaria Initiative could risk 67 million lives, report finds

November 22, 2017
Medical Communications, Research and Development Africa, Trump, USA, WHO, malaria, pharma

A team of researchers at Imperial College London (ICL) has argued that the proposal by US Congress to cut the …

Indivior’s opioid addiction treatment recommended by FDA advisory panel

November 1, 2017
Research and Development, Sales and Marketing FDA, RGP-6000, Trump, US, indivior, opioid crisis, opioids

Another step has been made in the fight back against the ongoing opioid crisis in the US as it emerges …

Latest content